Control of Gram-Negative Multidrug-Resistant Pathogens

doi:10.1017/9781107153165.018

Chapter 17 - Control of Gram-Negative Multidrug-Resistant Pathogens

from Section 4 - Antimicrobial-Resistant Organisms

Published online by Cambridge University Press: 02 April 2018

Pranita Tamma, and

Edited by

Emily K. Shuman and

Ebbing Lautenbach: Affiliation:
University of Pennsylvania School of Medicine
Preeti N. Malani: Affiliation:
University of Michigan, Ann Arbor
Keith F. Woeltje: Affiliation:
Washington University School of Medicine, St Louis
Jennifer H. Han: Affiliation:
University of Pennsylvania School of Medicine
Emily K. Shuman: Affiliation:
University of Michigan, Ann Arbor
Jonas Marschall: Affiliation:
Washington University School of Medicine, St Louis

Book contents

Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type: Chapter
Information: Practical Healthcare Epidemiology , pp. 190 - 200

DOI: https://doi.org/10.1017/9781107153165.018 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

World Health Organization (WHO). www.who.int/drugresistance/documents/surveillancereport/en/. Accessed November 12, 2015.Google Scholar

Drees, M, Pineles, L, Harris, AD, Morgan, DJ. Variation in definitions and isolation procedures for multidrug-resistant Gram-negative bacteria: a survey of the Society for Healthcare Epidemiology of America Research Network. Infect Control Hosp Epidemiol. Apr 2014;35(4):362–366.CrossRef Google Scholar

Magiorakos, AP, Srinivasan, A, Carey, RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. Mar 2012;18(3):268–281.CrossRef Google Scholar PubMed

Tacconelli, E, Cataldo, MA, Dancer, SJ, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20 Suppl 1:1–55.CrossRef Google Scholar PubMed

World Health Organization (WHO). www.cdc.gov/nhsn/pdfs/ps-analysis-resources/phenotype_definitions.pdf. Accessed November 12, 2015.Google Scholar

Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; approved standard. Twenty-fourth informational supplement. CLSI Document M100-S24. Wayne, PA: CLSI 2014.Google Scholar

www.eucast.org/clinical_breakpoints/. Accessed November 12, 2015.Google Scholar

Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.CrossRef Google Scholar

Bush, K. The ABCD’s of B-lactamase nomenclature. J Infect Chemother. 2013; 19(4):549–559.10.1007/s10156-013-0640-7CrossRef Google Scholar

Castanheira, M, Farrell, SE, Krause, KM, Jones, RN, Sader, HS. Contemporary diversity of beta-lactamases among Enterobacteriaceae in the nine U.S. census regions and ceftazidime-avibactam activity tested against isolates producing the most prevalent beta-lactamase groups. Antimicrob Agents Chemother. 2014;58(2):833–838.10.1128/AAC.01896-13CrossRef Google Scholar PubMed

D’Andrea, MM, Arena, F, Pallecchi, L, Rossolini, GM. CTX-M-type beta-lactamases: a successful story of antibiotic resistance. Int J Med Microbiol. Aug 2013;303(6–7):305–317.CrossRef Google Scholar PubMed

Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. Nov 2008;29(11):996–1011.CrossRef Google Scholar

Guh, AY, Bulens, SN, Mu, Y, et al. Epidemiology of carbapenem-resistant enterobacteriaceae in 7 US communities, 2012–2013. JAMA. 2015;314(14):1479–1487.CrossRef Google Scholar PubMed

Perez, F, Van Duin, D. Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patients. Cleve Clin J Med. Apr 2013;80(4):225–233.CrossRef Google Scholar PubMed

Centers for Disease Control and Prevention (CDC). Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR. 2013;62(9):165–170.Google Scholar

Borer, A, Saidel-Odes, L, Riesenberg, K, et al. Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol. 2009;30(10):972–976.CrossRef Google Scholar PubMed

Gupta, N, Limbago, BM, Patel, JB, Kallen, AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60–67.10.1093/cid/cir202CrossRef Google Scholar PubMed

Satlin, MJ, Jenkins, SG, Walsh, TJ. The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies. Clin Infect Dis. 2014;58(9):1274–1283.10.1093/cid/ciu052CrossRef Google Scholar PubMed

Munoz-Price, LS, Poirel, L, Bonomo, RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013; 13(9):785–96.10.1016/S1473-3099(13)70190-7CrossRef Google Scholar PubMed

Nordmann, P, Naas, T, Poirel, L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791–1798.CrossRef Google Scholar PubMed

Kitchel, B, Rasheed, JK, Patel, JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53(8):3365–3370.CrossRef Google Scholar PubMed

Kaiser, RM, Castanheira, M, Jones, RN, Tenover, F, Lynfield, R. Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007–2009 SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis. Jul 2013;76(3):356–360.10.1016/j.diagmicrobio.2013.03.032CrossRef Google Scholar PubMed

Kumarasamy, KK, Toleman, MA, Walsh, TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancetl Infect Dis. 2010;10(9):597–602.CrossRef Google Scholar

Mathers, AJ, Hazen, KC, Carroll, J, et al. First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the New World. J Clin Microbiol. 2013; 51(2)680–683.10.1128/JCM.02580-12CrossRef Google Scholar PubMed

Centers for Disease Control (CDC). www.cdc.gov/hai/organisms/cre/definition.html. Accessed October 19, 2015.Google Scholar

Chea, N, Bulens, SN, Kongphet-Tran, T, et al. Improved phenotype-based definition for identifying carbapenemase producers among carbapenem-resistant Enterobacteriaceae. Emerg Infect Dis. 2015;21(9):1611–1616.CrossRef Google Scholar PubMed

Hrabak, J, Chudackova, E, Papagiannitsis, CC. Detection of carbapenemases in Enterobacteriaceae: a challenge for diagnostic microbiological laboratories. Clin Microbiol Infect. Sep 2014;20(9):839–853.10.1111/1469-0691.12678CrossRef Google Scholar PubMed

Hombach, M, von Gunten, B, Gastelberg, C, et al. Evaluation of the RAPIDEC® CARBA NP test for the detection of carbapenemases in Enterobacteriaceae. J Clin Microbiol 2015 Sep 30. pii: JCM.02327–15. Epub ahead of print.Google Scholar PubMed

Nordmann, P, Poirel, L, Dortet, L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503–1507.10.3201/eid1809.120355CrossRef Google Scholar PubMed

Pseudomonas dermatitis/folliculitis associated with pool and hot tubs: Colorado and Maine, 1999–2000. MMW. 2000;49(48):1087–1091.Google Scholar

Dixon, RS, Sydnor, CH. Puncture wound pseudomonal osteomyelitis of the foot. J Foot Ankle Surg. 1993; 32(4):434–442.Google Scholar PubMed

Wieland, M, Lederman, MM, Kline-King, C, et al. Left-sided endocarditis due to Pseudomonas aeruginosa: a report of 10 cases and review of the literature. Medicine (Baltimore). May 1986; 65(3):180–189.10.1097/00005792-198605000-00006CrossRef Google Scholar PubMed

Livermore, DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5):634–640.CrossRef Google Scholar PubMed

Maragakis, LL and Perl, TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46(8):1254–1263.10.1086/529198CrossRef Google Scholar PubMed

Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004. MMWR. 2004;53(45):1063–1066.Google Scholar

Lolans, K, Rice, TW, Munoz-Price, LS, Quinn, JP. Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother. 2006;50(9):2941–2945.CrossRef Google Scholar PubMed

Munoz-Price, LS, Arheart, K, Nordmann, P, et al. Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital. Crit Care Med. Dec 2013;41(12):2733–2742.10.1097/CCM.0b013e318298a541CrossRef Google Scholar PubMed

Thom, KA, Maragakis, LL, Richards, K, et al. Assessing the burden of Acinetobacter baumannii in Maryland: a statewide cross-sectional period prevalence survey. Infect Control Hosp Epidemiol. Sep 2012;33(9):883–888.Google Scholar PubMed

Harris, AD, McGregor, JC, Furuno, JP. What infection control interventions should be undertaken to control multidrug-resistant gram-negative bacteria? Clin Infect Dis Sept 2006:43 Suppl 2:S57–S61.10.1086/504479CrossRef Google Scholar PubMed

Williams, C, McGraw, P, Schneck, EE, et al. Impact of universal gowning and gloving on health care worker clothing contamination. Infect Control Hosp Epidemiol. 2015;36(4):431–437.10.1017/ice.2014.75CrossRef Google Scholar PubMed

Hayden, MK, Blom, DW, Lyle, EA, Moore, CG, Weinstein, RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients’ environment. Infect Control Hosp Epidemiol. 2008;29(2):149–154.10.1086/524331CrossRef Google Scholar PubMed

Snyder, GM, Thom, KA, Furuno, JP, et al. Detection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on the gowns and gloves of healthcare workers. Infect Control Hosp Epidemiol. 2008;29(7):583–589.CrossRef Google Scholar PubMed

Morgan, DJ, Liang, SY, Smith, CL, et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol. 2010;31(7):716–721.10.1086/653201CrossRef Google Scholar PubMed

Harris, AD, Perencevich, EN, Johnson, JK, et al. Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis. 2007;45(10):1347–1350.10.1086/522657CrossRef Google Scholar PubMed

Harris, AD, Kotetishvili, M, Shurland, S, et al. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Contrl. 2007;35(2):97–101.10.1016/j.ajic.2006.09.011CrossRef Google Scholar PubMed

Rock, C, Thom, KA, Masnick, M, Johnson, JK, Harris, AD, Morgan, DJ. Frequency of Klebsiella pneumoniae carbapenemase (KPC)-producing and non-KPC-producing Klebsiella species contamination of healthcare workers and the environment. Infect Control Hosp Epidemiol. 2014;35(4):426–429.10.1086/675598CrossRef Google Scholar PubMed

Cohen, CC, Cohen, B, Shang, J. Effectiveness of contact precautions against multidrug-resistant organism transmission in acute care: a systematic review of the literature. J Hosp Infect. 2015;90(4):275–284.10.1016/j.jhin.2015.05.003CrossRef Google Scholar PubMed

Kho, AN, Dexter, PR, Warvel, JS, et al. An effective computerized reminder for contact isolation of patients colonized or infected with resistant organisms. Int J Med Informatics. 2008;77(3):194–198.10.1016/j.ijmedinf.2007.02.005CrossRef Google Scholar PubMed

Palmore, TN, Henderson, DK. Managing transmission of carbapenem-resistant enterobacteriaceae in healthcare settings: a view from the trenches. Clin Infect Dis. 2013;57(11):1593–1599.10.1093/cid/cit531CrossRef Google Scholar PubMed

Schwaber, MJ, Lev, B, Israeli, A, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis. 1 2011;52(7):848–855.10.1093/cid/cir025CrossRef Google Scholar

Lucet, JC, Decre, D, Fichelle, A, et al. Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. Clin Infect Dis. 1999;29(6):1411–1418.CrossRef Google Scholar PubMed

Tamma, PD, Savard, P, Pal, T, Sonnevend, A, Perl, TM, Milstone, AM. An outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol. 2012;33(6):631–634.10.1086/665715CrossRef Google Scholar

Munoz-Price, LS, Hayden, MK, Lolans, K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol. 2010;31(4):341–347.CrossRef Google Scholar

Munoz-Price, LS, Quinn, JP. Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae. Curr Op Infect Dis. 2013;26(4):378–387.10.1097/01.qco.0000431853.71500.77CrossRef Google Scholar PubMed

Schwaber, MJ, Carmeli, Y. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Clin Infect Dis. Mar 2014;58(5):697–703.10.1093/cid/cit795CrossRef Google Scholar PubMed

Kramer, A, Schwebke, I, Kampf, G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.10.1186/1471-2334-6-130CrossRef Google Scholar

Denton, M, Wilcox, MH, Parnell, P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. Intensive Crit Care Nurs. Ar 2005;21(2):94–98.10.1016/j.iccn.2003.10.008CrossRef Google Scholar PubMed

Carling, PC, Parry, MF, Bruno-Murtha, LA, Dick, B. Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission. Crit Care Med. Apr 2010;38(4):1054–1059.CrossRef Google Scholar PubMed

Contamination, Hota B., disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis. Oct 2004;39(8):1182–1189.Google Scholar

Boyce, JM. Environmental contamination makes an important contribution to hospital infection. J Hosp Infect. Jun 2007;65, Suppl 2:50–54.10.1016/S0195-6701(07)60015-2CrossRef Google Scholar PubMed

Jawad, A, Seifert, H, Snelling, AM, Heritage, J, Hawkey, PM. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36(7):1938–1941.10.1128/JCM.36.7.1938-1941.1998CrossRef Google Scholar PubMed

Levin, AS, Gobara, S, Mendes, CM, Cursino, MR, Sinto, S. Environmental contamination by multidrug-resistant Acinetobacter baumannii in an intensive care unit. Infect Control Hosp Epidemiol. Nov 2001;22(11):717–720.10.1086/501852CrossRef Google Scholar

Catalano, M, Quelle, LS, Jeric, PE, Di Martino, A, Maimone, SM. Survival of Acinetobacter baumannii on bed rails during an outbreak and during sporadic cases. J Hosp Infect. 1999;42(1):27–35.10.1053/jhin.1998.0535CrossRef Google Scholar PubMed

Das, I, Lambert, P, Hill, D, Noy, M, Bion, J, Elliott, T. Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units. J Hosp Infect. 2002;50(2):110–114.10.1053/jhin.2001.1127CrossRef Google Scholar

Aygun, G, Demirkiran, O, Utku, T, et al. Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit. J Hosp Infect. 2002;52(4):259–262.CrossRef Google Scholar

Anaissie, EJ, Penzak, SR, Dignani, MC. The hospital water supply as a source of nosocomial infections: a plea for action. Arch Intern Med. 2002;162(13):1483–1492.10.1001/archinte.162.13.1483CrossRef Google Scholar PubMed

Bonten, MJ, Weinstein, RA. Transmission pathways of Pseudomonas aeruginosa in intensive care units: don’t go near the water. Crit Care Med. 2002;30(10):2384–2385.10.1097/00003246-200210000-00037CrossRef Google Scholar PubMed

Epstein, L, Hunter, JC, Arwady, MA, et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA. 2014;312(14):1447–1455.10.1001/jama.2014.12720CrossRef Google Scholar

Ha, J, Son, BK. Current Issues in duodenoscope-associated infections: now is the time to take action. Clin Endoscopy. 2015;48(5):361–363.10.5946/ce.2015.48.5.361CrossRef Google Scholar

Muscarella, LF. Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endoscopy. 2014;6(10):457–474.10.4253/wjge.v6.i10.457CrossRef Google Scholar PubMed

Calfee, D, Jenkins, SG. Use of active surveillance cultures to detect asymptomatic colonization with carbapenem-resistant Klebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol. 2008;29(10):966–968.10.1086/590661CrossRef Google Scholar PubMed

Snitkin, ES, Zelazny, AM, Thomas, PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Translational Med. 2012;4(148):148ra116.10.1126/scitranslmed.3004129CrossRef Google Scholar PubMed

Akduman, B, Akduman, D, Tokgoz, H, et al. Long-term fluoroquinolone use before prostate biopsy may increase the risk of sepsis caused by resistant microorganisms. Urology. 2011; 78(2):250–255.10.1016/j.urology.2011.02.065CrossRef Google Scholar PubMed

Boucher, HW, Talbot, GH, Bradley, JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009; 48(1):1–12.10.1086/595011CrossRef Google Scholar PubMed

Hsu, AJ and Tamma, PD. Treatment of multidrug-resistant Gram-negative infections in children. Clin Infect Dis May 2014; 58(10):1439–1448.10.1093/cid/ciu069CrossRef Google Scholar PubMed

Centers for Disease Control and Prevention (CDC). Centers for Disease Control (CDE). www.cdc.gov/drugresistance/pdf/ar-threats-2013–508.pdf. Accessed November 13, 2015.Google Scholar

Tamma, PD and Cosgrove, SE. Antimicrobial stewardship. Infec Dis Clin North Am 2011; 25(1):245–260.10.1016/j.idc.2010.11.011CrossRef Google Scholar PubMed

Marchaim, D, Chopra, T, Bhargava, A, et al. Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship. Infect Control Hosp Epidemiol. 2012;33(8):817–830.10.1086/666642CrossRef Google Scholar PubMed

Carmeli, Y, Lidji, SK, Shabtai, E, Navon-Venezia, S, Schwaber, MJ. The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study. Diagn Microbiol Infect Dis. 2011;70(3):367–372.10.1016/j.diagmicrobio.2011.03.009CrossRef Google Scholar PubMed

Dortch, MJ, Fleming, SB, Kauffmann, RM, Dossett, LA, Talbot, TR, May, AK. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infecti. 2011;12(1):15–25.10.1089/sur.2009.059CrossRef Google Scholar PubMed

Rahal, JJ, Urban, C, Horn, C, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998;280(14):1233–1237.10.1001/jama.280.14.1233CrossRef Google Scholar PubMed

Ntagiopoulos, PG, Paramythiotou, E, Antoniadou, A, et al. Impact of an antibiotic restriction policy on the antibiotic resistance patterns of Gram-negative microorganisms in an intensive care unit in Greece. Int J Antimicrob Agents. 2007; 30:360–365.10.1016/j.ijantimicag.2007.05.012CrossRef Google Scholar

Altunsoy, A, Aypak, C, Azap, A, et al. The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci. 2011;4:339–344.10.7150/ijms.8.339CrossRef Google Scholar

Davey, P, Brown, E, Charani, E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Systematic Review Apr 20134:CD003543. doi:10.1002/14651858.CD003543.pub3.CrossRef Google Scholar

Roquilly, A, Marret, E, Abraham, E, Asehnoune, K. Pneumonia prevention to decrease mortality in intensive care unit: a systematic review and meta-analysis. Clin Infect Dis. 2015;60(1):64–75.10.1093/cid/ciu740CrossRef Google Scholar PubMed

Price, R, MacLennan, G, Glen, J, Su, DC. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta-analysis. BMJ. 2014;348:g2197.10.1136/bmj.g2197CrossRef Google Scholar PubMed

de Smet, AM, Kluytmans, JA, Blok, HE, et al. Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study. Lancet Infect Dis. 2011;11(5):372–380.10.1016/S1473-3099(11)70035-4CrossRef Google Scholar PubMed

Oostdijk, EA, Kesecioglu, J, Schultz, MJ, et al. Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial. JAMA. 2014;312(14):1429–1437.10.1001/jama.2014.7247CrossRef Google Scholar PubMed

Lin, MY, Lolans, K, Blom, DW, et al. The effectiveness of routine daily chlorhexidine gluconate bathing in reducing Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol. 2014;35(4):440–442.10.1086/675613CrossRef Google Scholar PubMed

Septimus, EJ, Hayden, MK, Kleinman, K, et al. Does chlorhexidine bathing in adult intensive care units reduce blood culture contamination? A pragmatic cluster-randomized trial. Infect Control Hosp Epidemiol. 2014; 35 Suppl 3:S17–S22.10.1086/677822CrossRef Google Scholar PubMed

Milstone, AM, Elward, A, Song, X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet. 2013;381(9872):1099–1106.CrossRef Google Scholar PubMed

Climo, MW, Yokoe, DS, Warren, DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med. Feb 7 2013;368(6):533–542.10.1056/NEJMoa1113849CrossRef Google Scholar PubMed

Climo, MW, Sepkowitz, KA, Zuccotti, G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med. 2009;37(6):1858–1865.CrossRef Google Scholar PubMed

Hayden, MK, Lin, MY, Lolans, K, et al. Prevention of colonization and infection by Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae in long-term acute-care hospitals. Clin Infect Dis. 2015;60(8):1153–1161.10.1093/cid/ciu1173CrossRef Google Scholar PubMed

Brooks, SE, Walczak, MA, Hameed, R, et al. Chlorhexidine resistance in antibiotic-resistant bacteria isolated from the surfaces of dispensers of soap containing chlorhexidine. Infect Control Hosp Epidemiol. 2002; 23(11):692–695.10.1086/501996CrossRef Google Scholar PubMed

Tattawasart, U, Maillard, JY, Furr, JR, Russell, AD. Outer membrane changes in Pseudomonas stutzeri resistant to chlorhexidine diacetate and cetylpyridinium chloride. Int J Antimicrob Agents. 2000;16(3):233–238.10.1016/S0924-8579(00)00206-5CrossRef Google Scholar PubMed

Thomas, L, Maillard, JY, Lambert, RJ, Russell, AD. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a “residual” concentration. J Hosp Infect. 2000;46(4):297–303.10.1053/jhin.2000.0851CrossRef Google Scholar PubMed

Higgins, CS, Murtough, SM, Williamson, E, et al. Resistance to antibiotics and biocides among non-fermenting Gram-negative bacteria. Clin Microbiol Infect. 2001;7(6):308–315.10.1046/j.1198-743x.2001.00253.xCrossRef Google Scholar PubMed

Hilty, M, Betsch, BY, Bogli-Stuber, K, et al. Transmission dynamics of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the tertiary care hospital and the household setting. Clin Infect Dis. 2012;55(7):967–975.10.1093/cid/cis581CrossRef Google Scholar PubMed

Madigan, T, Johnson, JR, Clabots, C, et al. Extensive household outbreak of urinary tract infection and intestinal colonization due to extended-spectrum beta-lactamase-producing Escherichia coli sequence type 131. Clin Infect Dis. 2015;61(1):e5–12.10.1093/cid/civ273CrossRef Google Scholar PubMed

Doi, Y, Park, YS, Rivera, JI, et al. Community-associated extended-spectrum beta-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013;56(5):641–648.10.1093/cid/cis942CrossRef Google Scholar PubMed

Gould, CV, Rothenberg, R, Steinberg, JP. Antibiotic resistance in long-term acute care hospitals: the perfect storm. Infect Control Hosp Epidemiol. 2006;27(9):920–925.10.1086/507280CrossRef Google Scholar PubMed

O’Fallon, E, Pop-Vicas, A, The Emerging, D’Agata E. Threat of multidrug-resistant gram-negative organisms in long-term care facilities. J Ger Ser A. 2009; 64(1):138–141.10.1093/gerona/gln020CrossRef Google Scholar PubMed

Mills, JP, Talati, NJ, Alby, K, Han, JH. The epidemiology of carbapenem-resistant Klebsiella pneumoniae colonization and infection among long-term acute care hospital residents. Infect Control Hosp Epidemiol. 12 2015:1–6.Google Scholar

Lin, MY, Lyles-Banks, RD, Lolans, K, et al. The importance of long-term acute care hospitals in the regional epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis. 2013;57(9):1246–1252.CrossRef Google Scholar PubMed

O’Fallon, E, Gautam, S, D’ Agata, EM. Colonization with multidrug-resistant gram-negative bacteria: prolonged duration and frequent colonization. Clin Infect Dis. 2009;48(10):1375–1381.10.1086/598194CrossRef Google Scholar

Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Healthcare Infection Control Practices Advisory C: management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007;35(10 Suppl 2):S165–S193.10.1016/j.ajic.2007.10.006CrossRef Google Scholar

Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Health Care Infection Control Practices Advisory C. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. Am J Infect Control. 2007;35(10 Suppl 2):S65–S164.10.1016/j.ajic.2007.10.007CrossRef Google Scholar

Centers for Disease Control and Prevention (CDC). ww.cdc.gov/hai/organisms/cre/cre-toolkit/index.html. Accessed November 13th, 2015.Google Scholar

Feldman, N, Adler, A, Molshatzki, N, et al. Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. Clin Microbiol Infect. 2013;19(4):E190–196.10.1111/1469-0691.12099CrossRef Google Scholar PubMed

Oren, I, Sprecher, H, Finkelstein, R, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: a prospective controlled trial. Am J Infecti Control. 2013;41(12):1167–1172.10.1016/j.ajic.2013.04.018CrossRef Google Scholar PubMed

Accessibility standard: Unknown

Why this information is here

This section outlines the accessibility features of this content - including support for screen readers, full keyboard navigation and high-contrast display options. This may not be relevant for you.

Accessibility Information

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.